Evaluation of a Couple-Based Physical Activity Intervention

Description

This clinical trial tests how well a couple-based physical activity (PA) intervention, Mates in Motion, works in patients undergoing hematopoietic cell transplantation (HCT) or chimeric antigen receptor T-cell therapy (CART) and their care giving partners to be more physically active. Mates in Motion provides training in communication skills and behavior change techniques to help HCT patient-caregiver dyads support one another in adoption and maintenance of PA. This study may help researchers determine if a couple-based PA intervention improves PA, physical endurance and global physical health among patient-care giver dyads undergoing HCT or CART.

Conditions

Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm

Study Overview

Study Details

Study overview

This clinical trial tests how well a couple-based physical activity (PA) intervention, Mates in Motion, works in patients undergoing hematopoietic cell transplantation (HCT) or chimeric antigen receptor T-cell therapy (CART) and their care giving partners to be more physically active. Mates in Motion provides training in communication skills and behavior change techniques to help HCT patient-caregiver dyads support one another in adoption and maintenance of PA. This study may help researchers determine if a couple-based PA intervention improves PA, physical endurance and global physical health among patient-care giver dyads undergoing HCT or CART.

Mates in Motion: Feasibility and Acceptability of a Couple-Based Physical Activity Intervention

Evaluation of a Couple-Based Physical Activity Intervention

Condition
Hematopoietic and Lymphoid System Neoplasm
Intervention / Treatment

-

Contacts and Locations

Scottsdale

Mayo Clinic in Arizona, Scottsdale, Arizona, United States, 85259

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * PATIENTS: Age 18 years or older
  • * PATIENTS: Scheduled to receive an autologous or allogeneic hematopoietic cell transplant (HCT) or chimeric antigen receptor (CAR)-T cell therapy
  • * PATIENTS: Able to speak and comprehend English
  • * PATIENTS: Being married or in a committed (self-defined) cohabiting same- or opposite-sex relationship
  • * PATIENTS: Physician-approved for a walking program
  • * CAREGIVERS: Age 18 years or older
  • * CAREGIVERS: Able to speak and comprehend English
  • * CAREGIVERS: Married to or in a committed, cohabiting, same- or opposite-sex relationship with the patient
  • * CAREGIVERS: Able to participate in a walking program
  • * None per se beyond the converse of the inclusions listed above, for example, age younger than 18 years and non-partnered

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Mayo Clinic,

Nandita Khera, MD, MPH, PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

2025-06-30